Abstract
Objective
Racial disparities in rates of pneumococcal vaccine (PPSV23) exist. In one practice, 3.1 % of white patients refused PPSV23 following doctor recommendation, whereas 11.2 % of black patients refused vaccination. Our objective was to understand reasons black patients refused PPSV23.
Methods
Mixed-method telephone survey in 2012 of black patients aged ≥65 with a documented refusal of PPSV23. The survey assessed beliefs about PPSV23; reasons for non-receipt of PPSV23; receipt of other vaccinations; and comparative perceptions of adult vs. childhood vaccines. Participants responded to items on a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).
Results
Participants’ (N = 40) mean age was 73 years; 95 % were female. Participants recognized pneumonia could be deadly (M = 4.3, SD = 1.0), but reported low levels of personal susceptibility (M = 2.8, SD = 1.4). Participants perceived childhood vaccines to be safer (M = 4.2, SD = 1.2) than adult vaccines (M = 3.4, SD = 1.4; p < 0.01). Qualitative analyses to understand reasons for refusal of vaccine both reinforced identified low perceptions of personal susceptibility as well as identified numerous additional barriers to receipt of PPSV23 (e.g., fear, side effects, and mistrust).
Conclusions
Black patients in our sample who refused PPSV23 may not perceive themselves susceptible to the disease, suggesting that strategies to improve PPSV23 rates among these patients may need to emphasize susceptibility to pneumonia. Further, given the discrepancies in perceptions toward childhood versus adult vaccinations, focusing on vaccination across the lifespan may be a promising vaccine promotion strategy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae 2012.
Nuorti PJ, Butler JC, Breiman RF. Prevention of pneumococcal disease: recommendations of the advisory committee on immunization practices (ACIP). Morb Mortal Wkly Rep. 1997;46:1–24.
Nuorti JP, Whitney CG. Updated recommendations for preventive of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). Morb Mortal Wkly Rep. 2010;59:1102–6.
Centers for Disease Control and Prevention 2014;Pages http://www.cdc.gov/nchs/nhis/released201403.htm#5 on June 12 2014.
O’Malley AS, RForrest CB. Immunization disparities in older Americans: determinants and future research needs. Am J Prev Med. 2006;31:150–8.
Santibanez TA, Zimmerman RK. Immunizations in adulthood. Prim Care. 2002;29(3):649–65.
Santibanez TA, Nowalk MP, Zimmerman RK, Jewell IK, Bardella IJ, Wilson SA, et al. Knowledge and beliefs about influenza, pneumococcal disease, and immunizations among older people. J Am Geriatr Soc. 2002;50(10):1711–6.
Jones LG, Zhang Y, Ahmed MI, Ekundaya OJ, Akhter S, Sawyer P, et al. Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans. J Am Geriatr Soc. 2010;58:2323–8.
Zimmerman RK, Santibanez TA, Fine MJ, Janosky JE, Nowalk MP, Bardella IJ, et al. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine. 2003;21(13–14):1510–7.
Persell SD, Kaiser D, Dolan NC, Andrews B, Levi S, Khandekar J, et al. Changes in performance after implementation of a multifaceted electronic-health-record-based quality improvement system. Med Care. 2011;49(2):117–25.
Jean-Jacques M, Persell SD, Thompson JA, Hasnain-Wynia R, Baker DW. What accounts for the gap: the contribution of differences in patient preference and clinical appropriateness to racial differences in performance on ambulatory care quality measures. Phoenix, AZ: Society of General Internal Medicine; 2014.
Jean-Jacques M, Persell SD, Thompson JA, Hasnain-Wynia R, Baker DW. Changes in disparities following the implementation of a health information technology-supported quality improvement initiative. J Gen Intern Med. 2012;27(1):71–7.
Brownfield E, Marsden JE, Iverson PJ, Zhao Y, Mauldin PD, Moran WP. Point of care experience with pneumococcal and influenza vaccine documentation among persons aged ≥65 years: high refusal rates and missing information. Am J Infect Control. 2012;40(7):672–4.
Winston CA, Wortley PM, Lees KA. Factors associated with vaccination of medicare beneficiaries in five U.S. communities: results from the racial and ethnic adult disparities in immunization initiative survey, 2003. J Am Geriatr Soc. 2006;54(2):303–10.
Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr. 1974;2:328–35.
Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11:1–47.
Witte K. Putting the fear back in fear appeals: the extended parallel process model. Commun Monogr. 1992;59:330–49.
Witte K. Fear control and danger control: a test of the extended process model (EPPM). Commun Monogr. 1994;61:113–34.
Cameron KA, Rintamaki LS, Kamanda-Kosseh M, Noskin GA, Baker DW, Makoul G. Using theoretical constructs to identify key issues for targeted message design: African American seniors’ perceptions about influenza and influenza vaccination. Health Commun. 2009;24(4):316–26.
Cialdini RB. Influence: science and practice. 4th ed. Needham Heights, MA: Allyn & Bacon; 2001.
Freedman JL, Fraser SC. Compliance without pressure: the foot-in-the-door technique. J Pers Soc Psychol. 1966;4:195–203.
Lincoln YS, Guba EG. Naturalistic inquiry. Beverly Hills, CA: SAGE; 1985.
Strauss AL, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques: Sage Publications; 1990.
The American Association for Public Opinion Research. Standard definitions: final dispositions of case codes and outcome rates for surveys. 7th Edition. AAPOR; 2011.
Ridda I, Motbey C, Lam L, Lindley IR, McIntyre PB, Macintyre CR. Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient’s perception, attitude, and knowledge. Vaccine. 2008;26(2):234–40.
Harris LM, Chin NP, Fiscella K, Humiston S. Barrier to pneumococcal and influenza vaccinations in Black elderly communities: mistrust. J Natl Med Assoc. 2006;98(10):1678–84.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
We confirm that all patient/personal identifiers have been removed so the patient/person(s) described are not identifiable and cannot be identified through the details of the story.
Conflict of Interest
Dr. Persell receives grant support from Pfizer, Inc. All other authors report no conflicts of interest. The study sponsor had no role in the study design; collection, analysis or interpretation of data; writing the report; or the decision to submit this report for publication.
Financial Disclosure
All authors of this paper report no financial disclosures.
Funding Support
Funding support was provided by the Agency for Healthcare Research and Quality (P01HS21141).
Rights and permissions
About this article
Cite this article
Brown, T., Goldman, S.N., Acosta, F. et al. Understanding Black Patients’ Refusal of Pneumococcal Vaccination. J. Racial and Ethnic Health Disparities 4, 1–8 (2017). https://doi.org/10.1007/s40615-015-0193-9
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s40615-015-0193-9